USA
Meldepflichtige Eigengeschäfte von Führungskräften (Directors' Dealings) gemäß Art. 19 MAR – wer im eigenen Unternehmen kauft und verkauft.
Datenstand: 23.10.2026 (gestern)
| Gemeldet ↓ | Geschäft | Unternehmen | Insider | Position | Art | Volumen |
|---|---|---|---|---|---|---|
| 01.10.2026 | 01.10.2026 | SEA Ltd. | Yanjun Wang | CCO and GC | Verkauf | 25.671,36 USD |
| 01.10.2026 | 01.10.2026 | SEA Ltd. | Feng Zhao | President of Garena | Verkauf | 716.746,52 USD |
| 01.10.2026 | 01.10.2026 | SEA Ltd. | Feng Zhao | President of Garena | Verkauf | 1.441.899,20 USD |
| 01.10.2026 | 01.10.2026 | SEA Ltd. | Feng Zhao | President of Garena | Verkauf | 1.642.232,13 USD |
| 01.10.2026 | 01.10.2026 | Perion Network Ltd. | Eyal Kaplan | Director | Verkauf | 25.413,81 USD |
| 01.10.2026 | 01.10.2026 | Perion Network Ltd. | Joy Sharon Marcus | Director | Verkauf | 14.723,96 USD |
| 01.10.2026 | 01.10.2026 | Perion Network Ltd. | Michael Vorhaus | Director | Verkauf | 18.827,06 USD |
| 01.10.2026 | 01.10.2026 | Enlight Renewable Energy Ltd. | Ilan Goren | GENERAL MANAGER, ENLIGHT US | Verkauf | 174.987,00 USD |
| 01.10.2026 | 01.10.2026 | Enlight Renewable Energy Ltd. | Nir Yehuda | CFO | Verkauf | 84.728,44 USD |
| 01.10.2026 | 01.10.2026 | Exlservice Holdings, Inc. | Vikas Bhalla | President of EXL | Verkauf | 389.180,00 USD |
| 01.10.2026 | 01.10.2026 | Globalfoundries Inc. | Samak L. Azar | Chief Legal Officer | Verkauf | 16.053,20 USD |
| 01.10.2026 | 02.10.2026 | Cardlytics, Inc. | Amit Gupta | Chief Executive Officer / Director | Verkauf | 18.698,61 USD |
| 01.10.2026 | 01.10.2026 | Cardlytics, Inc. | Amit Gupta | Chief Executive Officer / Director | Verkauf | 28.051,21 USD |
| 01.10.2026 | 01.10.2026 | Cactus, Inc. | Joel Bender | President / Director / 10% Owner | Verkauf | 6.197.300,00 USD |
| 01.10.2026 | 01.10.2026 | Cactus, Inc. | Scott Bender | Chairman and CEO / Director / 10% Owner | Verkauf | 6.197.300,00 USD |
| 01.10.2026 | 01.10.2026 | Spyre Therapeutics, Inc. | Cameron Turtle | Chief Executive Officer / Director | Verkauf | 9.391,00 USD |
| 01.10.2026 | 01.10.2026 | Spyre Therapeutics, Inc. | Cameron Turtle | Chief Executive Officer / Director | Verkauf | 465.916,30 USD |
| 01.10.2026 | 01.10.2026 | Spyre Therapeutics, Inc. | Cameron Turtle | Chief Executive Officer / Director | Verkauf | 368.224,59 USD |
| 01.10.2026 | 01.10.2026 | Spyre Therapeutics, Inc. | Cameron Turtle | Chief Executive Officer / Director | Verkauf | 241.350,62 USD |
| 01.10.2026 | 01.10.2026 | Spyre Therapeutics, Inc. | Cameron Turtle | Chief Executive Officer / Director | Verkauf | 241.738,30 USD |
| 01.10.2026 | 01.10.2026 | Spyre Therapeutics, Inc. | Cameron Turtle | Chief Executive Officer / Director | Verkauf | 53.484,00 USD |
| 01.10.2026 | 01.10.2026 | Spyre Therapeutics, Inc. | Heidy King-Jones | See Remarks | Verkauf | 242.996,00 USD |
| 01.10.2026 | 01.10.2026 | Spyre Therapeutics, Inc. | Heidy King-Jones | See Remarks | Verkauf | 194.670,00 USD |
| 01.10.2026 | 01.10.2026 | Spyre Therapeutics, Inc. | Heidy King-Jones | See Remarks | Verkauf | 660.277,80 USD |
| 01.10.2026 | 01.10.2026 | Spyre Therapeutics, Inc. | Heidy King-Jones | See Remarks | Verkauf | 1.500.261,75 USD |
| 01.10.2026 | 01.10.2026 | Spyre Therapeutics, Inc. | Heidy King-Jones | See Remarks | Verkauf | 35.696,00 USD |
| 01.10.2026 | 01.10.2026 | Gilead Sciences, Inc. | Daniel Patrick O'Day | Chairman & CEO / Director | Verkauf | 445.879,50 USD |
| 01.10.2026 | 01.10.2026 | Gilead Sciences, Inc. | Daniel Patrick O'Day | Chairman & CEO / Director | Verkauf | 1.772.628,00 USD |
| 01.10.2026 | 01.10.2026 | Outfront Media Inc. | Matthew Siegel | EVP, CFO | Verkauf | 696.000,00 USD |
| 01.10.2026 | 01.10.2026 | Docusign, Inc. | Allan C. Thygesen | President and CEO / Director | Verkauf | 362.286,46 USD |
| 01.10.2026 | 01.10.2026 | Docusign, Inc. | Allan C. Thygesen | President and CEO / Director | Verkauf | 944.381,10 USD |
| 01.10.2026 | 01.10.2026 | Docusign, Inc. | Allan C. Thygesen | President and CEO / Director | Verkauf | 512.261,75 USD |
| 01.10.2026 | 01.10.2026 | Maze Therapeutics, Inc. | Jason V. Coloma | Chief Executive Officer / Director | Verkauf | 862.186,07 USD |
| 01.10.2026 | 01.10.2026 | Maze Therapeutics, Inc. | Jason V. Coloma | Chief Executive Officer / Director | Verkauf | 70.073,49 USD |
| 01.10.2026 | 01.10.2026 | Mgic Investment Corp. | Salvatore A. Miosi | President & COO | Verkauf | 781.800,00 USD |
| 01.10.2026 | 01.10.2026 | Natera, Inc. | Steven Leonard Chapman | CEO AND PRESIDENT / Director | Verkauf | 526.143,63 USD |
| 01.10.2026 | 01.10.2026 | Liquidity Services Inc. | John Daunt | EVP, Chief Commercial Officer | Verkauf | 16.629,75 USD |
| 01.10.2026 | 01.10.2026 | Liquidity Services Inc. | John Daunt | EVP, Chief Commercial Officer | Verkauf | 13.936,50 USD |
| 01.10.2026 | 01.10.2026 | Stoke Therapeutics, Inc. | Barry Ticho | CHIEF MEDICAL OFFICER | Verkauf | 27.493,53 USD |
| 01.10.2026 | 01.10.2026 | Clover Health Investments, Corp. | Andrew Toy | Chief Executive Officer / Director | Verkauf | 1.335.797,14 USD |
| 01.10.2026 | 01.10.2026 | Vaxcyte, Inc. | Jim Wassil | EVP, Chief Scientific Ofc, COO | Verkauf | 5.423,93 USD |
| 01.10.2026 | 01.10.2026 | Vaxcyte, Inc. | Jim Wassil | EVP, Chief Scientific Ofc, COO | Verkauf | 122.089,37 USD |
| 01.10.2026 | 01.10.2026 | Planet Labs PBC | Ita M. Brennan | Director | Verkauf | 187.478,75 USD |
| 01.10.2026 | 01.10.2026 | Docusign, Inc. | Paula Hansen | Chief Revenue Officer | Verkauf | 20.811,00 USD |
| 01.10.2026 | 01.10.2026 | Docusign, Inc. | Paula Hansen | Chief Revenue Officer | Verkauf | 206.250,00 USD |
| 01.10.2026 | 01.10.2026 | Xeris Biopharma Holdings, Inc. | Beth Hecht | See Remarks | Verkauf | 156.792,06 USD |
| 01.10.2026 | 01.10.2026 | Xeris Biopharma Holdings, Inc. | Kevin McCulloch | See Remarks | Verkauf | 141.120,00 USD |
| 01.10.2026 | 01.10.2026 | Xeris Biopharma Holdings, Inc. | Steven Pieper | See Remarks | Verkauf | 47.036,50 USD |
| 01.10.2026 | 02.10.2026 | Xometry, Inc. | Randolph Altschuler | Director | Verkauf | 9.891,27 USD |
| 01.10.2026 | 02.10.2026 | Xometry, Inc. | Randolph Altschuler | Director | Verkauf | 140.956,18 USD |